Skip to main content
. 2020 Nov 9;2(11):e0268. doi: 10.1097/CCE.0000000000000268

TABLE 1.

Baseline Characteristics

Baseline Characteristics Entire Cohort n = 64 Survived to Discharge n = 34 Death Prior to Discharge n = 30 p
Age, yr, mean (sd) 44 (14) 39 (14) 51 (13) 0.0007
Gender, n (%), male 44 (69) 23 (68) 21 (70) 1.0
Body mass index, mean (sd) 30.7 (7.2) 32.1 (8.1) 29.2 (5.7) 0.1
Hypertension, n (%) 11 (17.1) 7 (20.6) 4 (13.3) 0.5
Diabetes, n (%) 11 (17) 5 (14.7) 6 (20) 0.4
Prior myocardial infarction, n (%) 2 (3.1) 0 (0) 2 (6.7) 0.2
Congestive heart failure, n (%) 4 (6.3) 2 (5.9) 2 (6.7) 1
Coronary artery disease, n (%) 3 (4.7) 2 (5.8) 1 (3.3) 1
Peripheral vascular disease, n (%) 2 (3.1) 1 (2.9) 1 (3.3) 1
Cerebral vascular accident, n (%) 0 (0) 0 (0) 0 (0) n/a
Chronic obstructive pulmonary disease, n (%) 5 (7.8) 2 (5.8) 3 (10) 0.4
Reactive airway disease, n (%) 3 (4.7) 2 (5.9) 1 (3.3) 1
Interstitial lung disease, n (%) 16 (25) 9 (26) 7 (23) 1
Chronic kidney disease, n (%) 3 (4.7) 1 (2.9) 2 (6.7) 0.6
Liver disease, n (%) 3 (4.7) 2 (5.9) 1 (3.3) 1
Malignancy, n (%) 5 (7.8) 1 (2.9) 4 (13.3) 0.2
Hepatitis C virus, n (%) 3 (4.7) 2 (5.8) 1 (3.3) 1
Charlson Comorbidity Score, mean (sd) 1.3 (1.4) 0.8 (1.0) 1.9 (1.5) 0.0008
Simplified Acute Physiology Score II score, mean (sd) 37.8 (9.5) 36.3 (10.2) 39.5 (8.5) 0.18
Sequential Organ Failure Assessment score, mean (sd) 8.3 (3.2) 9 (3.5) 7.6 (2.8) 0.08
Number of patients on vasopressora, n (%) 38 (60) 22 (65) 21 (70) 0.6
Number of patients on inotropesa, n (%) 14 (22) 9 (26) 5 (17) 0.5
Prone positioning, n (%) 30 (47) 15 (44) 15 (50) 0.8
Days intubated prior to cannulation, mean (sd) 4.3 (0.6) 4.4 (0.9) 4.2 (0.7) 0.8
Serum creatininea, mean (sd) 1.7 (1.2) 1.7 (1.3) 1.6 (1.2) 0.5
Serum albumina, mean (sd) 2.3 (0.8) 2.5 (0.9) 2.1 (0.6) 0.04
Hemoglobina, mean (sd) 9.9 (2.0) 10.1 (1.9) 9.7 (2.3) 0.4
pHa, mean (sd) 7.2 (0.1) 7.2 (0.2) 7.3 (0.1) 0.6
Po2a, mean (sd) 61 (12.7) 60 (12.3) 61 (13.1) 0.9
Pco2a, mean (sd) 63 (23.9) 60 (23.5) 66 (24.4) 0.3
Po2/Fio2a, mean (sd) 63 (22.8) 58 (20.8) 69 (23.9) 0.05

aLast known value prior to cannulation.